Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Diffusely infiltrating, frequently bilateral glial tumor involving at least 3 lobes
Infiltrative extent of tumor is out of proportion to histologic and clinical features
T2 hyperintense infiltrating mass with enlargement of involved structures
Typical cerebral hemispheres (75%)
Brain architecture enlarged, distorted, but preserved
Typically no or minimal enhancement
Enhancement may indicate malignant progression or focus of malignant glioma
MRS: Increased choline, decreased NAA
Arteriolosclerosis
Vasculitis
Anaplastic astrocytoma
Viral encephalitis
Demyelination
Usually WHO grade III; range grade II-IV
Shares many features of diffusely infiltrating astrocytoma
Rarely, oligodendroglioma is predominant cell type
Diagnosis typically made on basis of histology and imaging
Presenting symptoms: Mental status changes, dementia, headaches, seizures, lethargy
Treatment: Biopsy for diagnosis, ± radiation and chemotherapy
Peak incidence between 40-50 years, occurs at all ages
Relentless progression
Survival ranges from weeks to years
Median survival ~ 14 months
Gliomatosis cerebri (GC)
Gliomatosis, diffuse cerebral gliomatosis
Diffusely infiltrating, frequently bilateral glial tumor involving at least 3 lobes
Infiltrative extent of tumor is out of proportion to histologic and clinical features
Best diagnostic clue
T2 hyperintense infiltrating mass with enlargement of involved structures
Location
Typically hemispheric white matter (WM) involvement (76%), may also involve cortex (19%)
3 lobes, diffuse WM plus
Basal ganglia, thalami (75%)
Brainstem (52%)
Corpus callosum (50%)
Cerebellum (29%)
Spinal cord (9%)
May cross corpus callosum or massa intermedia
Morphology
Infiltrates, enlarges yet preserves underlying brain architecture
NECT
Poorly defined, asymmetric low density (often subtle)
Loss of gray-white differentiation with expansion and mild mass effect
CECT
No enhancement typical
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here